News for 'API'

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

Telangana plant explosion toll rises to 36; FIR against factory mgmt

Telangana plant explosion toll rises to 36; FIR against factory mgmt

Rediff.com1 Jul 2025

The death toll from the explosion at the Sigachi Industries' pharma plant in Pashamylaram has risen to 35, police said on Tuesday.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

'Algo Trading Is Not Risk-Free'

'Algo Trading Is Not Risk-Free'

Rediff.com23 Dec 2024

Many enter this arena without a detailed understanding of how their algo works.' 'Diligently review information on the strategy, risk profile, potential losses, and expected gains before investing.'

Sundar Pichai's Future-Proof Career Tips

Sundar Pichai's Future-Proof Career Tips

Rediff.com11 Jun 2025

'Skills like critical thinking, empathy, storytelling, team management and ethical judgment will grow in value even as AI continues to master logical tasks,' says Alphabet and Google CEO Sundar Pichai.

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Rediff.com23 May 2025

India's largest drug maker Sun Pharmaceutical on Thursday posted a decline of 19 per cent year-on-year (Y-o-Y) for its consolidated net profit for the fourth quarter of the financial year 2025 (Q4FY25) at Rs 2,149.8 crore. Meanwhile, its revenue from operations rose by 8 per cent at Rs 12,958.8 crore.

Lessons For Start Ups From UPI Success Story

Lessons For Start Ups From UPI Success Story

Rediff.com14 Apr 2025

Isn't there something significant in the UPI example for all of us to learn from and execute to enable world-scale success for our startups?, asks Ajit Balakrishnan.

Mutual Funds Emerge As Financiers For M&A Deals

Mutual Funds Emerge As Financiers For M&A Deals

Rediff.com6 Feb 2025

'Growth for some companies has been hard to come by and this is a smart way to get there.'

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Google Unveils AI For India's Developers

Google Unveils AI For India's Developers

Rediff.com18 Jul 2024

Developers in India now have expanded access to Google's powerful AI models with the 2 million token context window in Gemini 1.5 Pro and Gemma 2, the next generation of open models.

5 cops behind Badlapur sexual assault accused's death: Report

5 cops behind Badlapur sexual assault accused's death: Report

Rediff.com20 Jan 2025

A magistrate's inquiry has found five policemen responsible for the custodial death of Akshay Shinde, who was accused in the Badlapur school sexual assault case. The Bombay High Court ordered an FIR to be registered against the five policemen, following the magistrate's report. Shinde was arrested in August 2024 for allegedly assaulting two minor girls and was killed in an alleged police shootout in September while being taken from prison for questioning. The police claimed he snatched a gun and opened fire, but the magistrate found the five officers responsible for his death. The court has asked the public prosecutor to inform the bench in two weeks on which probe agency will investigate the case.

Badlapur school sexual assault accused opens fire at police, shot dead

Badlapur school sexual assault accused opens fire at police, shot dead

Rediff.com24 Sep 2024

An official said Akshay Shinde, who worked as a cleaner at the school, was being taken to Badlapur from Taloja jail for investigation.

ChatGPT Downtime: Wake-up Call For AI

ChatGPT Downtime: Wake-up Call For AI

Rediff.com13 Dec 2024

The outage raised broader concerns about the dependency on a few large tech companies controlling critical platforms.

'The formulations business been a growth driver'

'The formulations business been a growth driver'

Rediff.com24 Feb 2024

'However, we have seen weakness in our active pharmaceutical ingredients business.'

618 Drugs 'Not Of Standard Quality'

618 Drugs 'Not Of Standard Quality'

Rediff.com9 Dec 2024

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.

CID to probe encounter killing of Badlapur accused

CID to probe encounter killing of Badlapur accused

Rediff.com24 Sep 2024

A team of forensic science experts on Tuesday examined the police vehicle, in which Shinde was allegedly shot by a cop on Monday evening, they said. Shinde, 24, was accused of sexually assaulting two minor girls at a school in Badlapur town of Thane district.

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

'Focus Is To Maintain The Casa Ratio'

'Focus Is To Maintain The Casa Ratio'

Rediff.com8 Nov 2024

'It has remained around 38 per cent over the past four to five quarters.'

Leaked CoWIN data is from past breach, no direct theft, claims govt

Leaked CoWIN data is from past breach, no direct theft, claims govt

Rediff.com12 Jun 2023

While asserting that the CoWIN portal is completely safe with adequate safeguards for data privacy, it said an internal exercise has been initiated to review the existing security measures of CoWIN.

Want To Invest In Pharma & Healthcare?

Want To Invest In Pharma & Healthcare?

Rediff.com5 Nov 2024

'A long-term investor with a 4 to 5 year horizon could invest in this theme via SIPs.'

Average cost of data breaches in India hits $2.18 million: RBI report

Average cost of data breaches in India hits $2.18 million: RBI report

Rediff.com30 Jul 2024

The average cost of data breaches in India reached $2.18 million in 2023, marking a 28 per cent increase since 2020, according to the Reserve Bank of India's (RBI) Currency and Finance report for 2023-24. The report said that India's average data breach cost was still below the global average. The most common attacks in India are phishing which was at 22 per cent and stolen or compromised credentials was 16 per cent. The automotive industry is highly vulnerable to cyber attacks, whereas the banking and financial services sector, benefiting from stringent regulations, enjoys comparatively stronger protection.

Google unveils a slate of AI tools for Indian developers

Google unveils a slate of AI tools for Indian developers

Rediff.com29 Jun 2023

Google unveiled on Wednesday a slate of artificial intelligence (AI) tools and technologies for Indian developers at its first I/O Connect event for India, being held in Bengaluru. The company made accessible for Indian developers its faster, more accurate large language AI model accessible through PaLM API, Makersuite, as well as features on Google Cloud's Vertex AI. Google Cloud officially launched a new initiative in collaboration with Open Network for Digital Commerce (ONDC), under the Department for Promotion of Industry and Internal Trade, to help sellers build and scale commerce platforms across the country.

Digital Competition Bill Wants Interoperability

Digital Competition Bill Wants Interoperability

Rediff.com19 Feb 2024

It is being suggested that apps, such as WhatsApp and Telegram, should share their APIs with each other to ensure there is interoperability, just as it exists across email services.

Badlapur accused's encounter: 'Wrong to say he fired'

Badlapur accused's encounter: 'Wrong to say he fired'

Rediff.com24 Sep 2024

The family members of Badlapur sexual assault case accused Akshay Shinde have challenged the police claim that he fired at a policeman first following which cops fired in self-defence which led to his death.

Kerala Sets Up Digital Cheque Bounce Court

Kerala Sets Up Digital Cheque Bounce Court

Rediff.com17 Aug 2024

'Digital courts will alleviate congestion in traditional courts.'

Lower input costs may aid pharma firms' Q2 margins

Lower input costs may aid pharma firms' Q2 margins

Rediff.com21 Oct 2024

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Rediff.com30 Jan 2024

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for niche drugs in the US market, fall in raw material prices and correction in shipping rates. In the healthcare segment, hospitals are expected to post revenue growth of 13 per cent during the coverage, while net profit growth would be around 37 per cent, ICICI Securities said in a note. However, the performance may not be comparable on a sequential basis due to the offset of the festive season in Q3FY24, the analysts noted.

RBI set to launch UPI-like unified lending platform

RBI set to launch UPI-like unified lending platform

Rediff.com27 Aug 2024

The Reserve Bank of India (RBI) will launch the Unified Lending Interface (ULI) nationwide in due course, aiming to transform India's lending sector, similar to how the Unified Payments Interface (UPI) revolutionised the payments ecosystem, Governor Shaktikanta Das said on Monday.

'Second-gen promoters more open to selling out'

'Second-gen promoters more open to selling out'

Rediff.com6 Jun 2024

'There is not any negative connotation associated with it.'

Sania's 'Kitty Doll' Turns 1!

Sania's 'Kitty Doll' Turns 1!

Rediff.com16 Aug 2023

'We celebrated our little Dua's birthday yesterday... the sweetest and the smiliest baby who lights up our home with laughter and pure love.'

Nirma's new clothes: The journey of detergent brand towards healthcare

Nirma's new clothes: The journey of detergent brand towards healthcare

Rediff.com12 Oct 2023

Nirma's tryst with the pharmaceutical space started in 2006 when it acquired the ailing Core Healthcare in a deal reported to be worth Rs 300 crore. The Ahmedabad-based manufacturer of intravenous fluids was subsequently renamed Nirlife. Pharma industry insiders say Nirma, which broke open the detergent market in the 1990s with low prices and massive advertising, tried an encore of the low-price strategy in pharma, but with mixed results.

Sebi's proposal can restrict growth of algo trading: Brokers

Sebi's proposal can restrict growth of algo trading: Brokers

Rediff.com13 Dec 2021

Markets regulator Sebi's proposal of treating all orders emanating from application programming interface (API) as algorithmic or algo order can restrict the growth of such trading in India, brokerage houses said on Monday. In market parlance, algo trading refers to any order that is generated using automated execution logic. The algo trading system automatically monitors the live stock prices and initiates an order when the given criteria are met.

Software startup Postman's valuation tops $5.6 bn after $225 mn fundraise

Software startup Postman's valuation tops $5.6 bn after $225 mn fundraise

Rediff.com19 Aug 2021

Postman, a leading application programming interface platform, has secured $225 million in a Series D round, placing its valuation at $5.6 billion. With this, Postman has emerged as the most-valued software-as-a-service (SaaS) firm started by Indian founders, overtaking web and mobile testing firm BrowserStack, which was valued at $4 billion in June. The valuation of the San Francisco-headquartered firm with offices in Bengaluru, where it was founded, has almost trebled in just about one year and risen multi-fold since 2019. Postman, with team members spread across four continents, had secured $150 million in a Series C investment round led by Insight Partners at a $2-billion valuation last summer.

Looking For A Broker? Read This!

Looking For A Broker? Read This!

Rediff.com1 Nov 2023

'The stockbroker should have a good balance sheet to support its scale of operations. It should also have proper risk management in terms of margins so that it doesn't go bankrupt during extreme market movements.' 'The broker must have a track record of navigating several market cycles in an ethical and transparent manner.'

For the first time, Centre allows a private player to process opium

For the first time, Centre allows a private player to process opium

Rediff.com14 Jul 2022

The central government has for the first time allowed a private company, Bajaj Healthcare, to process opium to extract alkaloids used to make pain-killers, cough syrups, and even cancer drugs. Two government factories in Ghazipur, Uttar Pradesh, and Neemuch, Madhya Pradesh, do the work yet, processing some 800 tonnes of opium gum annually to extract alkaloids. The government on Tuesday gave Thane-based Bajaj Healthcare an initial contract to process 500 tonnes of opium gum annually and wants production to be at 800 tonnes per annum (tpa) in the next five years, indicating the state's exit from the highly-regulated sector.

Pharma, consumer durables sectors likely to feel China curb heat

Pharma, consumer durables sectors likely to feel China curb heat

Rediff.com12 Dec 2022

The pharmaceutical and the consumer durables sectors, which depend on China for imports, have not been impacted yet due to unrest in China with people protesting against lockdowns. But the lockdown could have an impact on the supply of components used in consumer durables if it continues for the next fortnight. In the pharmaceutical industry, Indian players import 66-70 per cent of their bulk drug requirements from China.

Bihar man, teen arrested for CoWIN data leak via Telegram

Bihar man, teen arrested for CoWIN data leak via Telegram

Rediff.com22 Jun 2023

A man from Bihar was arrested and a juvenile was apprehended in connection with their involvement in the alleged data leak from CoWIN portal, officials said on Thursday.

'Banks must be prepared for providing UPI credit'

'Banks must be prepared for providing UPI credit'

Rediff.com19 Jul 2024

'A credit line on UPI is going to make banks think about credit fundamentally as they digitise the credit process entirely.'

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Sachin Dhas: The prodigy who defied all odds

Sachin Dhas: The prodigy who defied all odds

Rediff.com7 Feb 2024

Living up to name: Beed's Little Sachin Dhas lives his father's dream